LYTIR

Company · AIM

AIM ImmunoTech Inc.

Nasdaq's symbol directory lists AIM on NYSE American as “AIM ImmunoTech Inc. Common Stock”.

In the 12 months to Nov 8, 2026: insiders bought on 7 occasions ($27K); 2 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $27K in total; Insider sales: $0 in total.Sep: Insider purchases $13KOct: Insider purchases $10KNov: Insider purchases $3KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $27KInsider sales below: $0
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Thomas K. Equels, CEO & President bought on 7 days latest Nov 6, 2026 bought $27K
Every trade (7)
  1. BUYThomas K. Equels, CEO & President bought Nov 6, 2026 20,299 shares filing $3K
  2. BUYThomas K. Equels, CEO & President bought Oct 23, 2026 31,675 shares filing $5K
  3. BUYThomas K. Equels, CEO & President bought Oct 22, 2026 31,250 shares filing $5K
  4. BUYThomas K. Equels, CEO & President bought Sep 17, 2026 24,000 shares filing $5K
  5. BUYThomas K. Equels, CEO & President bought Sep 16, 2026 11,000 shares filing $2K
  6. BUYThomas K. Equels, CEO & President bought Sep 15, 2026 22,000 shares filing $5K
  7. BUYThomas K. Equels, CEO & President bought Sep 14, 2026 5,900 shares filing $1K

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Regulation FD disclosure filing Nov 5, 2026
  2. Entry into a material definitive agreement; Unregistered sales of equity securities filing Sep 14, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.